Member News
-
Nano One Awarded US$12.9M by US Department of Defense to Support the Expansion of North American LFP Production at Candiac Facility
September 26, 2024 (Source) — (TSX:NANO)(OTC PINK:NNOMF)(Frankfurt:LBMB) Highlights: DPA Title III office awards US$12.9M (~CA$17.8M) to Nano One.…
-
Appia Confirms Discovery of Uranium and Rare Earth Element Mineralization in Exploratory Drill Holes at the Loranger Project, Saskatchewan, Canada
September 26, 2024 (Source) — Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FWB: A0I0) (MUN: A0I0)…
-
Voyageur Pharmaceuticals Grants Stock Options
September 25, 2024 (Source) — Voyageur Pharmaceuticals Ltd. (TSXV: VM) (OTC Pink: VYYRF) (“Voyageur” or the “Company”) announces that…
-
ArcStone Securities and Investments Corp. Announces Strategic Global Expansion with the Launch of ArcStone Israel Securities and Investments USA Corp. as New Partners
September 25, 2024 (Source) — ArcStone Securities and Investments Corp. (“ASIC”), a premier cross-border financial services firm, today…
-
FuelPositive Provides Updates on Site Approvals and Project Timeline
Manitoba Government Support Approvals and Project Timeline Update The Path Forward Carbon Credit Update Featured Industry Presentations Preparing…
-
Voyageur Pharmaceuticals Strengthens Leadership Team with Strategic Appointment of Dr. Ibrahim Hashmi as VP of Business Development
September 24, 2024 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) (“Voyageur” or the “Company”) is pleased…
-
EXIM Bank Issues Letter of Interest to Fund up to US$456M for Wyoming Rare Earth Project
September 24, 2024 (Source) — Highlights Wyoming Rare (USA) Inc. has received a non-binding Letter of Interest from…
-
Scandium Canada Ltd. files patent application for aluminium-scandium alloys for 3D printing
September 23, 2024 (Source) — Scandium Canada Ltd. (the “Company” or “Scandium Canada”) (TSX VENTURE: SCD; OTCQB: SCDSCF) is pleased to…
-
DIAGNOS Announces Variation in One Insider Ownership
September 20, 2024 (Source) — In accordance with regulatory requirements, Diagnos Inc. (“DIAGNOS”, the “Corporation” or the “Issuer”) (TSX…
